抗凝血剤の世界市場2017-2021...市場調査レポートについてご紹介

【英文タイトル】Global Anticoagulant Market 2017-2021

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents

PART 01: Executive summary 

PART 02: Scope of the report 

Market overview 
Top-vendor offerings 

PART 03: Market research methodology 

Research methodology 
Economic indicators 

PART 04: Introduction 

Key market highlights 

PART 05: Disease overview 

PART 06: Pipeline analysis 

PART 07: Market landscape 

Market overview 
Five forces analysis 

PART 08: Market segmentation by ROA 

Oral anticoagulants 
Injectable anticoagulants 

PART 09: Market segmentation by drug class 
Factor Xa inhibitors 
DTIs 
Heparin 
Vitamin K antagonists 

PART 10: Market segmentation by application 

DVT 
PE 
AF 
Others 

PART 11: Geographical segmentation 

Global anticoagulant market in Americas 
Anticoagulant market in EMEA 
Anticoagulant market in APAC 

PART 12: Market drivers 

Increasing demand for NOACs 
Growing prevalence of coagulation disorders 
Increase in hip and knee surgeries 

PART 13: Impact of drivers 

PART 14: Market challenges 

Increasing cost of NOACs 
Lack of antidotes in the market for NOACs 
Patent expiry: a threat to market 

PART 15: Impact of drivers and challenges 

PART 16: Market trends 

Strategic alliance 
Increasing focus toward emerging economies 
Patient assistance programs 

PART 17: Vendor landscape 

Competitive scenario 
Other prominent vendors 

PART 18: Key vendor analysis 

Bayer HealthCare 
Boehringer Ingelheim 
Bristol-Myers Squibb 
Daiichi Sankyo 
Johnson & Johnson 
Sanofi 

PART 19: Appendix 

List of abbreviations 

PART 20: Explore Technavio 

[List of Exhibits]

Exhibit 01: Product offerings 

Exhibit 02: Process of blood coagulation 

Exhibit 03: Mechanism of action (MoA) of anticoagulant 

Exhibit 04: Key customer segments of global anticoagulant market 

Exhibit 05: Pipeline analysis 2016 

Exhibit 06: Key pipeline molecules 

Exhibit 07: Global anticoagulant market overview 

Exhibit 08: Global anticoagulant market 2016-2021 ($ billions) 

Exhibit 09: Five forces analysis 

Exhibit 10: Segmentation of anticoagulant market based on ROA 

Exhibit 11: Market share of anticoagulant based on ROA 2016 

Exhibit 12: Types of heparin 

Exhibit 13: Segmentation of anticoagulant market based on drug class 

Exhibit 14: Market share of anticoagulant based on drug class 2016 

Exhibit 15: Types of factor Xa inhibitors based on MOA 

Exhibit 16: Factor Xa inhibitors in global anticoagulant market 2016-2021 ($ billions) 

Exhibit 17: Types of DTIs based on MOA 

Exhibit 18: DTIs in global anticoagulant market 2016-2021 ($ billions) 

Exhibit 19: Global heparin market 2016-2021 ($ billions) 

Exhibit 20: Global vitamin K antagonists market in 2016-2021 ($ billions) 

Exhibit 21: Market segmentation by application 

Exhibit 22: Market segmentation of anticoagulant based on application 

Exhibit 23: Anticoagulant market in Americas 2016-2021 ($ billions) 

Exhibit 24: Anticoagulant market in EMEA 2016-2021 ($ billions) 

Exhibit 25: Anticoagulant market in APAC 2016-2021 ($ billions) 

Exhibit 26: Impact of drivers 

Exhibit 27: Patents to expire over forecast period 

Exhibit 28: Impact of drivers and challenges 

Exhibit 29: Competitive structure analysis of global anticoagulant market 2016 

Exhibit 30: Competitive analysis of global anticoagulant market 

Exhibit 31: Market share analysis 2016 

Exhibit 32: Competitive landscape analysis 2016 

Exhibit 33: Bayer HealthCare: Key highlights 

Exhibit 34: Bayer HealthCare: Strength assessment 

Exhibit 35: Bayer HealthCare: Strategy assessment 

Exhibit 36: Bayer HealthCare: Opportunity assessment 

Exhibit 37: Bayer HealthCare: YoY revenue and growth rate of XARELTO 2013-2015 ($ billions) 

Exhibit 38: Boehringer Ingelheim: Key highlights 

Exhibit 39: Boehringer Ingelheim: Strength assessment 

Exhibit 40: Boehringer Ingelheim: Strategy assessment 

Exhibit 41: Boehringer Ingelheim: Opportunity assessment 

Exhibit 42: Boehringer Ingelheim: YoY revenue and growth rate of PRADAXA (global) 2013-2015 ($ billions) 

Exhibit 43: Bristol-Myers Squibb: Highlights 

Exhibit 44: Bristol-Myers Squibb: Strength assessment 

Exhibit 45: Bristol-Myers Squibb: Strategy assessment 

Exhibit 46: Bristol-Myers Squibb: Opportunity assessment 

Exhibit 47: Bristol-Myers Squibb: YoY revenue and growth rate of ELIQUIS (global) 2013-2015 ($ millions) 

Exhibit 48: Bristol-Myers Squibb: Geographic segmentation of ELIQUIS 2015 

Exhibit 49: Daiichi Sankyo: Key highlights 

Exhibit 50: Daiichi Sankyo: Strength assessment 

Exhibit 51: Daiichi Sankyo: Strategy assessment 

Exhibit 52: Daiichi Sankyo: Opportunity assessment 

Exhibit 53: Johnson & Johnson: Strength assessment 

Exhibit 54: Johnson & Johnson: Strategy assessment 

Exhibit 55: Johnson & Johnson: Opportunity assessment 

Exhibit 56: Sanofi: Key highlights 

Exhibit 57: Sanofi: Strength assessment 

Exhibit 58: Sanofi: Strategy assessment 

Exhibit 59: Sanofi: Opportunity assessment 

Exhibit 60: Sanofi: YoY revenue and growth rate of LOVENOX (global) 2013-2015 ($ billions) 

Exhibit 61: Sanofi: Geographical segmentation of LOVENOX 2016  


【レポート販売概要】

■ タイトル:抗凝血剤の世界市場2017-2021
■ 英文:Global Anticoagulant Market 2017-2021
■ 発行日:2017年2月16日
■ 調査会社:Technavio
■ 商品コード:IRTNTR12016
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。